Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Eli Lilly and Co
LLY
Healthcare
Biotechnology
Eli Lilly and Company is a medicine company, which discovers, develops, manufactures and markets products in the human pharmaceutical products segment. Its cardiometabolic health products include Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity; Zepbound; VERVE...
-102; VERVE-201, and VERVE-301. Its oncology products include Cyramza, Erbitux, Tyvyt, and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. The Company, through its subsidiary, POINT Biopharma Global Inc., is engaged in radiopharmaceutical discovery, development, and manufacturing efforts, as well as clinical and pre-clinical radioligand therapies in development for the treatment of cancer. It is also developing an oral small molecule inhibitor of a4b7 integrin for inflammatory bowel disease (IBD).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NYSE:LLY)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 16, 2024 4:15pm
New Press Release - Lilly announces retirement of Marschall S. Runge from its Board of Directors
INDIANAPOLIS, Aug. 16, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that Marschall S. Runge, M.D., Ph.D. is retiring from his role as an independent director of Lilly's board of directors effective Aug. 31, 2024.Dr. Runge has served on Lilly's board since 2013, including...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 16, 2024 8:40am
New Press Release - Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease
Broadens Lilly's immunology pipeline with Morphic's oral integrin therapies, including MORF-057Reinforces the company's strategy of delivering potential first or best-in-class therapies in the field of gastroenterologyINDIANAPOLIS, Aug. 16, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 13, 2024 8:00am
New Press Release - Lilly opens state-of-the-art research and development center in the Boston Seaport
Lilly Seaport Innovation Center (LSC) serves as the central hub for Lilly's genetic medicines efforts and houses the first East Coast Lilly Gateway LabsNew 346,000 square foot facility will accommodate approximately 500 Lilly scientists and researchers, in addition to 200 people from Lilly...
read article.
(34)
•••
E30S14
X
Post by
E30S14
on Aug 08, 2024 2:48pm
Monster
Eli Lilly and Company is a monster. $844.16 72.015 | 9.33% Bid: 843.34 x 400 Ask: 844.97 x 300 Volume: 6,229,157 USD
...more
(34)
•••
E30S14
X
Comment by
E30S14
on Jun 25, 2024 11:05pm
RE:RE:Another new high for LLY
This little soldier keeps on thumpin' and pumpin' $904.61 14.5 | 1.63% Bid: 902.84 x 100 Ask: 909.00 x 100 Volume:
...more
(34)
•••
E30S14
X
Comment by
E30S14
on Jun 13, 2024 10:47pm
RE:Another new high for LLY
Yet another new high for LLY. $883.33 16.03 | 1.85% Bid: 878.36 x 200 Ask: 883.00 x 200 Volume: 2,243,419 USD
...more
(34)
•••
E30S14
X
Post by
E30S14
on Jun 10, 2024 8:55pm
Another new high for LLY
I love this company and the stock. But how much higher can LLY go?? $865.00 15.01 | 1.77% Bid: 883.00 x 100 Ask: 885.00 x 100
...more
(111)
•••
jboom70
X
Post by
jboom70
on Feb 08, 2024 10:59am
Watching
For healthcare rotation. Looking to enter on pullback.
(28)
•••
satchmo6
X
Post by
satchmo6
on Feb 05, 2024 3:11pm
actually rising
been watching since 2010
(2)
•••
jw1trader
X
Post by
jw1trader
on Sep 28, 2022 3:01pm
stock has been faring very well on the stock market
currently forming a flat base with an ideal buy point of 335.43, according to MarketSmith analysis. Shares are currently sitting under the 50-day moving average, hitting resistance there
...more
(28)
•••
satchmo6
X
Comment by
satchmo6
on Sep 17, 2021 11:58am
RE:Putin said he will squash this company
DOWN 2 bucks----its starting------
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
The first public copper company permitted to drill in Argentina’s newly opened Mendoza province
Pinnacle Extends Gold-Silver Mineralized Horizon to Almost 500 Metres at Historic La Dura Mine
Eshbal Signs Definitive Agreement to Acquire Majority Interest in NYC-Based Dare to Be Different Foods
Allied Critical Metals Confirms Ultra High-Grade Tungsten Zone at Borralha
SALT: quietly powering industries, keeping roads safe, and even shaping the global economy